Delivery Order SPE2DB24D9802-SPE2DB25FJLFC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,708.87 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Ondansetron HCL 4 mg tablets (30-count units). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, operates under a firm fixed-price structure with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,052.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Ondansetron ODT 4 mg tablets (30-count packaging) on August 12, 2025, with completion targeted for August 13, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The place of performance is Conshohocken, Pennsylvania. No set-aside designation was used for this award,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This contract, valued at $3,664.15 with an ultimate completion date of August 6, 2025, carries no set-aside designation and represents a single delivery order under the DLA's broader pharmaceutical supply...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,986.59 by the Defense Logistics Agency on September 8, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30. This delivery order, which carries no set-aside designation, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $12,021.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,558,233,358 units of Ondansetron HCL 4 mg tablets. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA. The IDC allows the DLA to issue firm...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,758.80 contract is for the delivery of ondansetron orally disintegrating tablets, 8 mg, in 30-count packages. DMS Pharmaceutical Group holds a larger indefinite delivery/indefinite quantity (ID/IQ) contract, number 4600082013, with the Defense Logistics Agency under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,615.21 firm fixed-price delivery order is for the provision of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $3,034.47, is for Ondansetron HCL 4 mg tablets in a 30-count package. The order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm...
- This federal contract award was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,399.77 firm fixed-price delivery order is for the supply of 4,564,618,079 units of Ondansetron HCL 4 MG Tablet 500S to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,111.66 firm fixed-price delivery order is for the supply of 4,566,601,038 units of the prescription drug Ondansetron HCl 4 mg tablets. The contract has an ultimate completion date of December 4, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC)...
- SPE2DB24D9802Indefinite Delivery Contract
- SPE2DB24D9802-SPE2DB25FJLFCDelivery Order
The Defense Logistics Agency awarded a $8,789.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Ondansetron HCl 4 mg tablets (500 count). The order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products to support military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for government contracts. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare sites. Ondansetron, a commonly prescribed anti-nausea medication, represents the type of essential pharmaceutical product the company routinely supplies to military medical facilities across the nation, supporting the DLA's mission to provide medical supplies to defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 9/12/25 |